Summary

Darou Darman Arang is a fast growing pharmaceutical Company in Iran.

Our Story

We are a fast growing pharmaceutical company manufacturing our own brands and representing  pharmaceutical companies from around the world in Iran to import medicines.

DAROU DARMAN ARANG acts as the representative agent for specialty, rare disease, biotech and vaccine producing companies looking to penetrate to Iran. We are the preferred strategic partner, providing turn-key solutions and support for their commercial operations……  Read more 

 

Manufacturing

We have ensured world-class quality in design, equipment and operations in our manufacturing facility. Our units ensure that we are able to provide best-in-class products to patients across the Iran and emerging markets around. Our manufacturing operations are focused on producing generics and branded generics, in the full range of dosage forms, including tablets, capsules, injectable, pre-filled syringe and freeze dried powder. ……  Read more 

 

Imports of Finished Pharmaceuticals

As the pioneer of our mission to meet the needs of the health society across IRAN and beyond with our expert staffs and facilities to import different health care products…… Read more 

Summary

Research & Development Department

We in R&D department aimed to Reach to various market requirements and high quality products, by representing formulation and providing new method analysis, taking advantage of experienced Experts, using the most up to dated sources of pharmaceuticals and advanced devices. In addition to exploitation of cooperation and consultation of prominent University professors and other authentic science centers.

Read More

Activities

Regulatory

Having sufficient knowledge of drug registration rules & regulations for registration of products
Adequately capability of registering new products in the Drug National List
Well knowledge of the drug, raw material and food supplement approval process and registration bureaucracy in Ministry of Health
Submitting registration documents to MOH

Read More

DAROU DARMAN ARANG COMPANY WAS ESTABLISHED BY A GROUP OF EXPERIENCED PEOPLE TO ATTRACT, DEVELOP AND DELIVER NEW CAPABILITIES.

Featured products

Latest news

[ News Archive ]

31 Jul

Sustainable biosimilar policies in Europe

A review of approaches to biosimilar policy in Europe [1] highlights key principles for a sustainable biosimilar market, including supporting innovation and allowing for multiple suppliers.

31 Jul

US policy brief identifies barriers to biosimilars uptake

It was projected that by 2026, biosimilars could save up to US$150 billion in the specialty pharmaceuticals market. However, in the US, it has emerged that there are inherent barriers to market entry [1]. These obstruct greater biosimilar commercialization and uptake, making it difficult to achieve large healthcare savings that were hoped for. To date, the US Food and Drug Administration (FDA) has approved 26 biosimilars [2], yet most of these are not currently available to patients.

31 Jul

EC approval for Sanofi’s insulin aspart biosimilar

The European Commission (EC) has issued marketing authorization for Sanofi’s insulin aspart biosimilar, which references Novo Nordisk’s product NovoLog and is used to treat type 1 and 2 diabetes.

Copyright © 2020 Darou Darman Arang Co. All rights reserved.